HIGHLIGHTS
- who: Yoshihito Uchida and collaborators from the Faculty of Medicine, Department of Gastroenterology and Hepatology, Saitama University, Saitama, Japan have published the article: Superiority of tenofovir alafenamide fumarate over entecavir for serum HBsAg level reduction in patients with chronic HBV infection: A 144-week outcome study after switching of the nucleos(t)ide analog, in the Journal: PLOS ONE of 18/02/2022
- what: In the present study, the effects of TAF and ETV on the serum lipid profiles were also compared, since the serum total cholesterol levels were reported, by previous studies, to increase . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.